AzTrials
AzTrials

OsteopeniaFeDeBoMaNCT06813092

Effects of Resistance Exercise Compared to Whole-body Electromyostimulation in Young Female Dentists.

A study testing Whole-Body Electromyostimulation and Resistance exercise in people with Osteopenia and Cardiometabolic Conditions, run by University of Erlangen-Nürnberg Medical School at 2 sites in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Due to their high workload and unfavorable working position, young female dentists are particularly at risk of cardiometabolic diseases and an early reduction in bone mineral density (BMD). Read more about this study

Who is it for?
Ages 18 to 30 years, women only
Conditions the study is for
Osteopenia, Cardiometabolic Conditions
What is being tested?
Whole-Body Electromyostimulation and Resistance exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
2 sitesGermany
Study dates
15 Mar 2025to 30 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • female dental students (>3rd semester) or licensed dentists
  • no competitive sports background for >2 years
  • normal body mass (BMI>18,5 and <25 kg/m2)

Who cannot join

  • more than one resistance exercise session per week (last 12 month)
  • whole-body electromyostimulation during the last 12 month
  • amenorrhea, oligomenorrhea

Trial locations and contacts

2 sites in 1 country.

Germany2 sites
  • Institute of Radiology

    Erlangen, 91052

  • Institute of Radiology, University Hospital NErlangen

    Erlangen, 91054

Other trials in Germany

About this study

Official title: Effects of a Single Bout of High Intensity, High Velocity Resistance Exercise Compared to Whole-body Electromyostimulation on Cardiometabolic Risk Factors and Markers of Bone Formation and -Resorption in Young Female Dentists.

Due to their high workload and unfavorable working position, young female dentists are particularly at risk of cardiometabolic diseases and an early reduction in bone mineral density (BMD). With focus on the latter issue, short bouts of resistance exercise with high strain magnitude and velocity are commonly considered to be a feasible option to prevent bone loss in the early years of young adulthood. In parallel, whole-body electromyostimulation (WB-EMS) a trainings technology able address all main muscle groups simultaneously, however with dedicated exercise intensity might be a time-effective, joint friendly and safe option to maintain BMD in people unable or unmotivated to exercise conventionally. In the present study, we aim to compare the effects of a single session of WB-EMS versus high intensity, high velocity resistance exercise on biomarkers of bone formation (Procollagen type 1 N propeptide, P1NP) and resorption (C-terminal telopeptide of type I collagen, CTX-I). We hypothesize that no clinically relevant different effects on P1NP and CTX-I were determined.

Being tested
Whole-Body Electromyostimulation, Resistance exercise
Keywords
biomarkers, bone metabolism, exercise, whole-body electromyostimulation, female dentists
Medical subject headings
Bone Diseases, Metabolic, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Whole-Body ElectromyostimulationOther

    20 min of WB-EMS (bipolar, 85 Hz, 350 µs, 6s impulse - 4s impulse break)

  • Resistance exerciseOther

    High-intensity/high velocity multiple set resistance exercise

Study groups in NCT06813092
Study groupRoleWhat they receive
Whole-Body ElectromyostimulationExperimentalOne single bout of whole-body electromyostimulation (20 min, bipolar, 85 Hz, 350 µs, rectangular, 6s of impulse, 4s of rest)
Receives: Other: Whole-Body Electromyostimulation
Resistance exerciseActive comparatorHigh intensity, high velocity resistance exercise (30 min, 5-6 exercises, 3 sets at 60-85% 1RM)
Receives: Other: Resistance exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes for C-terminal telopeptide of type I collagen from pre- to 15 min post-exercise

    Changes for C-terminal telopeptide of type I collagen (CTX-I) serum levels from pre- to 15 min post-exercise as determined by blood samples

    Measured: Immediately pre-exercise to 15 min post exercise of a single exercise session

Secondary outcomes (3)
  1. Changes for Procollagen type 1 N propeptide from pre- to 15 min post-exercise

    Changes for Procollagen type 1 N propeptide (P1NP) serum levels from pre- to 15 min post-exercise as determined by blood samples

    Measured: Immediately pre-exercise to 15 min post exercise of a single exercise session

  2. Changes for resting glucose from pre- to 15 min post-exercise

    Changes for resting glucose serum levels from pre- to 15 min post-exercise as determined by blood samples

    Measured: Immediately pr to 15 min post-exercise of a single exercise session

  3. Changes for hemoglobin A1c from pre- to 15 min post-exercise

    Changes for hemoglobin A1c (HBA1C) serum levels from pre- to 15 min post-exercise as determined by blood samples

    Measured: Immediately pre- to 15 min post-exercise of a single exercise session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2025
  2. Study start15 Mar 2025
  3. Primary completion15 Jul 2025
  4. Study completion30 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
Randomized two-arm cross-over design
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06813092
Sponsor's protocol ID
FeDeBoMa02
Other IDs
UKER
Acronym
FeDeBoMa
Status last verified
Jun 2025
First submitted
3 Feb 2025
Last updated
30 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Kemmler W, Bebenek M, von Stengel S, Bauer J. Peak-bone-mass development in young adults: effects of study program related levels of occupational and leisure time physical activity and exercise. A prospective 5-year study. Osteoporos Int. 2015 Feb;26(2):653-62. doi: 10.1007/s00198-014-2918-8. Epub 2014 Oct 7.

    PubMed 25288444

Questions about this trial

What is this clinical trial studying?

A study testing Whole-Body Electromyostimulation and Resistance exercise in people with Osteopenia and Cardiometabolic Conditions, run by University of Erlangen-Nürnberg Medical School at 2 sites in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes for C-terminal telopeptide of type I collagen from pre- to 15 min post-exercise (time frame: Immediately pre-exercise to 15 min post exercise of a single exercise session). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06813092, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in